Search

everythinglearnresearchcommunity

for

Search:↓

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A new treatment for hair loss shows promise with fewer side effects.

The mouse models are effective for testing new hair loss treatments.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Adding a second method to PROTACs could improve cancer treatment.

AH-001 could be a safer and more effective treatment for hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Androgen receptor degrader drugs may be a promising future treatment for hair loss.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

New method improves copper peptide delivery for hair growth three times better than current options.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Surgical robots have improved but still can't perform tasks or make decisions on their own.

18-MEA and cationic surfactants can restore and maintain hair's hydrophobic nature, improving its beauty and feel.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

New drug shows promise for better hair growth in baldness treatment.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.